Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active.

One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care.

And to identify if persons with TIA presents with cognitive impairments.


Clinical Trial Description

Transient ischemic attack (TIA) is a transient episode of neurologic dysfunction caused by ischemia, i.e. loss of blood flow. The symptoms of a TIA typically resolve within 24 hours. Attacks lasting more than 30 minutes are unusual. TIAs and strokes present with the same symptoms such as sudden weakness, numbness, sudden dimming or loss of vision, aphasia, slurred speech, facial palsy and mental impairments. Subtle problems with cognitive functions and fatigue may not always be addressed before discharge. However, even subtle mental impairments are important to identify, given the problems they might pose. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01509924
Study type Interventional
Source Tiohundra AB
Contact
Status Active, not recruiting
Phase N/A
Start date May 2010
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Recruiting NCT02662751 - Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA N/A
Completed NCT02038725 - MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack
Completed NCT01528462 - Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Withdrawn NCT00069069 - E-Selectin Nasal Instillation to Prevent Secondary Stroke Phase 1
Recruiting NCT02701998 - The Stroke and Exercise Program N/A
Completed NCT02450760 - Connected Health Blood Pressure Monitoring In Stroke and TIA Patients N/A
Completed NCT02089074 - Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack N/A
Completed NCT00250380 - The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study) Phase 4
Terminated NCT00991029 - Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial Phase 3
Completed NCT00061022 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Completed NCT02799511 - Biomarkers for the Diagnosis of Transient Ischemic Attack N/A
Completed NCT02415855 - Canadian Pradaxa Acute Stroke Safety Study
Completed NCT00514800 - Home Blood Pressure Monitoring Trial Phase 3
Recruiting NCT00553241 - Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score N/A
Active, not recruiting NCT00201461 - Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO) Phase 2/Phase 3
Completed NCT00119626 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Terminated NCT05961163 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
Completed NCT00590980 - Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) N/A
Terminated NCT00029146 - Carotid Occlusion Surgery Study Phase 3